Phase I trial of interferon alfa-n3 in early-stage human immunodeficiency virus type 1 disease: Evidence for drug safety, tolerance, and antiviral activity

Donald R. Skillman, Joseph L. Malone, Catherine F. Decker, Kenneth F. Wagner, Robert L. Mapou, Mei June Liao*, Douglas Testa, Monte S. Meltzer

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of interferon alfa-n3 in early-stage human immunodeficiency virus type 1 disease: Evidence for drug safety, tolerance, and antiviral activity'. Together they form a unique fingerprint.

Medicine & Life Sciences